DECLARE TIMI 58
Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events (DECLARE-TIMI58)
- Stage
- klaar
- Medicine
- dapagliflozin
- Population
- Diabetes Mellitus
- Phase
- III
- First Patient In
- 1 June 2013
- Last Patient In
- 1 September 2014
- Last Patient Last Visit
- 11 July 2018
National Lead
dr. mr. A.J.M. Oude Ophuis
Cardioloog
Study Director